CD8A and neoplasm: Further analysis of T-cell subsets provided additional mechanistic insights, with observed changes to immune cell ratios that included increased tumor CD8:Treg levels, identifiable after one dose, and increased tumor T active eff:Treg and Teff : Texh levels, noted after the second dose.